Showing results (1171-1180 of 1,274) with videos related to

Sort By:
Pageof 128
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|January 30, 2020
Study design considerations for sleep-disordered breathing devicesEric A Mann, Srinivas Nandkumar, Nancy Addy, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2013
Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndromeGijsbert J A Nagtegaal, Christoph Pohl, Mike P Wattjes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donorsR J Soiffer, E Weller, E P Alyea, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 27, 2024
Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosisTomas Kalincik, Sifat Sharmin, Izanne Roos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 5, 2002
Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantationEdwin P Alyea, Edie Weller, David C Fisher, et al.
Gynecologic Oncology|February 27, 2021
Utilizing an interim futility analysis of the OVAL study (VB-111-701/GOG 3018) for potential reduction of risk: A phase III, double blind, randomized controlled trial of ofranergene obadenovec (VB-111) and weekly paclitaxel in patients with platinum resistant ovarian cancerRebecca C Arend, Bradley J Monk, Thomas J Herzog, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 29, 2025
Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosisTjalf Ziemssen, Mark S Freedman, Amit Bar-Or, et al.
Archives of Neurology|September 12, 2007
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year resultsFrederik Barkhof, Chris H Polman, Ernst-Wilhelm Radue, et al.
Annals of Clinical and Translational Neurology|April 19, 2020
Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosisSimon Thebault, Hyunwoo Lee, Gauruv Bose, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcomePhilippe Armand, Haesook T Kim, Vincent T Ho, et al.
Pageof 128